$2.6 Billion is the total value of Cormorant Asset Management, LP's 93 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was 29.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| TPTX | Sell | TURNING POINT THERAPEUTICS I | $213,359,000 | +20.7% | 2,442,297 | -10.8% | 8.20% | +21.6% |
| SPY | SPDR S&P 500 ETF TRput | $167,445,000 | +8.6% | 500,000 | 0.0% | 6.44% | +9.4% | |
| FMTX | FORMA THERAPEUTICS HLDGS INC | $166,465,000 | +9.1% | 3,379,373 | 0.0% | 6.40% | +10.0% | |
| RVMD | Buy | REVOLUTION MEDICINES INC | $91,878,000 | +11.0% | 2,640,177 | +0.1% | 3.53% | +11.9% |
| BBIO | Sell | BRIDGEBIO PHARMA INC | $85,011,000 | +0.6% | 2,265,762 | -12.5% | 3.27% | +1.4% |
| CCXI | Sell | CHEMOCENTRYX INC | $76,720,000 | -21.6% | 1,400,000 | -17.6% | 2.95% | -21.0% |
| IWM | ISHARES TRput | $74,895,000 | +4.6% | 500,000 | 0.0% | 2.88% | +5.4% | |
| RNA | Sell | AVIDITY BIOSCIENCES INC | $69,538,000 | +2.6% | 2,514,546 | -0.0% | 2.67% | +3.4% |
| SRNE | Sell | SORRENTO THERAPEUTICS INC | $66,900,000 | +63.9% | 6,000,000 | -7.7% | 2.57% | +65.1% |
| MYOK | Sell | MYOKARDIA INC | $61,349,000 | +5.8% | 450,000 | -25.0% | 2.36% | +6.6% |
| IMVT | New | IMMUNOVANT INC | $57,639,000 | – | 1,637,951 | +100.0% | 2.22% | – |
| APLS | Sell | APELLIS PHARMACEUTICALS INC | $56,300,000 | -16.6% | 1,866,108 | -9.7% | 2.16% | -15.9% |
| XLRN | Sell | ACCELERON PHARMA INC | $56,265,000 | -1.6% | 500,000 | -16.7% | 2.16% | -0.8% |
| XBI | SPDR SER TRput | $55,715,000 | -0.5% | 500,000 | 0.0% | 2.14% | +0.3% | |
| YMAB | Sell | Y-MABS THERAPEUTICS INC | $53,658,000 | -21.1% | 1,397,700 | -11.2% | 2.06% | -20.5% |
| ZYME | Buy | ZYMEWORKS INC | $53,567,000 | +170.0% | 1,150,000 | +109.1% | 2.06% | +172.1% |
| STOK | Sell | STOKE THERAPEUTICS INC | $51,501,000 | +27.0% | 1,537,807 | -9.6% | 1.98% | +28.0% |
| OMER | Buy | OMEROS CORP | $50,525,000 | +23.7% | 5,000,000 | +80.2% | 1.94% | +24.6% |
| EIDX | Sell | EIDOS THERAPEUTICS INC | $50,186,000 | -0.2% | 993,185 | -5.9% | 1.93% | +0.6% |
| MRTX | Sell | MIRATI THERAPEUTICS INC | $45,664,000 | -20.0% | 275,000 | -45.0% | 1.76% | -19.4% |
| VIE | Buy | VIELA BIO INC | $44,507,000 | -32.1% | 1,585,000 | +4.8% | 1.71% | -31.6% |
| RETA | Buy | REATA PHARMACEUTICALS INCcl a | $43,839,000 | -29.8% | 450,000 | +12.5% | 1.69% | -29.2% |
| TWST | Sell | TWIST BIOSCIENCE CORP | $37,985,000 | +51.7% | 500,000 | -9.6% | 1.46% | +52.8% |
| ALXO | New | ALX ONCOLOGY HLDGS INC | $35,959,000 | – | 971,770 | +100.0% | 1.38% | – |
| New | TRILLIUM THERAPEUTICS INC | $35,525,000 | – | 2,500,000 | +100.0% | 1.37% | – | |
| AXNX | Sell | AXONICS MODULATION TECHNOLOG | $35,371,000 | +39.8% | 693,000 | -3.8% | 1.36% | +40.9% |
| AGEN | Sell | AGENUS INC | $34,000,000 | -21.4% | 8,500,000 | -22.7% | 1.31% | -20.7% |
| BHVN | Sell | BIOHAVEN PHARMACTL HLDG CO L | $32,505,000 | -25.9% | 500,000 | -16.7% | 1.25% | -25.3% |
| RCKT | Sell | ROCKET PHARMACEUTICALS INC | $31,285,000 | +1.8% | 1,368,550 | -6.8% | 1.20% | +2.6% |
| ARCT | Sell | ARCTURUS THERAPEUTICS HLDGS | $30,030,000 | -19.7% | 700,000 | -12.5% | 1.16% | -19.1% |
| MYOV | Sell | MYOVANT SCIENCES LTD | $29,996,000 | -41.8% | 2,134,966 | -14.6% | 1.15% | -41.4% |
| AKRO | Buy | AKERO THERAPEUTICS INC | $26,466,000 | +79.2% | 859,550 | +45.1% | 1.02% | +80.8% |
| BPMC | Sell | BLUEPRINT MEDICINES CORP | $25,493,000 | -6.6% | 275,000 | -21.4% | 0.98% | -6.0% |
| CRSP | Sell | CRISPR THERAPEUTICS AGnamen akt | $25,092,000 | -14.6% | 300,000 | -25.0% | 0.96% | -14.0% |
| ALBO | New | ALBIREO PHARMA INC | $23,359,000 | – | 700,000 | +100.0% | 0.90% | – |
| CABA | Sell | CABALETTA BIO INC | $22,410,000 | -4.5% | 2,067,302 | -1.8% | 0.86% | -3.7% |
| BNTX | Buy | BIONTECH SEsponsored ads | $22,410,000 | +91.9% | 325,000 | +85.7% | 0.86% | +93.3% |
| BEAM | Sell | BEAM THERAPEUTICS INC | $19,608,000 | -11.0% | 796,428 | -0.0% | 0.75% | -10.3% |
| ASND | Sell | ASCENDIS PHARMA A/Ssponsored adr | $19,290,000 | -25.5% | 125,000 | -28.6% | 0.74% | -24.9% |
| GLPG | Buy | GALAPAGOS NVspon adr | $18,471,000 | -5.2% | 130,000 | +31.2% | 0.71% | -4.4% |
| AXSM | Sell | AXSOME THERAPEUTICS INC | $17,813,000 | -38.1% | 250,000 | -28.6% | 0.68% | -37.7% |
| IGMS | Sell | IGM BIOSCIENCES INC | $16,607,000 | -33.1% | 225,000 | -33.9% | 0.64% | -32.5% |
| ZLAB | Sell | ZAI LAB LTDadr | $15,727,000 | -23.4% | 189,092 | -24.4% | 0.60% | -22.7% |
| INSP | Sell | INSPIRE MED SYS INC | $15,486,000 | +20.3% | 120,000 | -18.9% | 0.60% | +21.2% |
| KURA | Sell | KURA ONCOLOGY INC | $15,320,000 | +34.3% | 500,000 | -28.6% | 0.59% | +35.4% |
| CCXI | Sell | CHEMOCENTRYX INCcall | $13,700,000 | -76.2% | 250,000 | -75.0% | 0.53% | -76.0% |
| PLRX | PLIANT THERAPEUTICS, INC | $13,571,000 | -27.9% | 611,409 | 0.0% | 0.52% | -27.3% | |
| OTIC | New | OTONOMY INC | $13,129,000 | – | 3,241,800 | +100.0% | 0.50% | – |
| DCPH | Sell | DECIPHERA PHARMACEUTICALS IN | $12,825,000 | -32.7% | 250,000 | -21.6% | 0.49% | -32.2% |
| TCRR | New | TCR2 THERAPEUTICS INC | $12,192,000 | – | 600,000 | +100.0% | 0.47% | – |
| QURE | Sell | UNIQURE NV | $11,970,000 | -40.2% | 325,000 | -26.8% | 0.46% | -39.8% |
| SRPT | Sell | SAREPTA THERAPEUTICS INC(NSM) | $11,937,000 | -32.3% | 85,000 | -22.7% | 0.46% | -31.8% |
| INSM | Sell | INSMED INC | $11,249,000 | -9.2% | 350,000 | -22.2% | 0.43% | -8.5% |
| AKUS | Buy | AKOUOS INC | $11,206,000 | +5.0% | 499,991 | +0.0% | 0.43% | +5.9% |
| RPTX | Sell | REPARE THERAPEUTICS INC | $10,725,000 | -2.0% | 348,567 | -1.2% | 0.41% | -1.4% |
| ARGX | Sell | ARGENX SEsponsored adr | $10,501,000 | -33.4% | 40,000 | -42.9% | 0.40% | -32.9% |
| QTNT | Sell | QUOTIENT LTD | $10,280,000 | -52.1% | 2,000,000 | -31.0% | 0.40% | -51.8% |
| OMER | New | OMEROS CORPcall | $10,110,000 | – | 1,000,000 | +100.0% | 0.39% | – |
| HARP | Sell | HARPOON THERAPEUTICS INC | $9,694,000 | -9.5% | 570,600 | -11.6% | 0.37% | -8.8% |
| TBPH | Buy | THERAVANCE BIOPHARMA INC | $9,611,000 | +357.9% | 650,072 | +550.1% | 0.37% | +362.5% |
| ANAB | Sell | ANAPTYSBIO INC | $9,588,000 | -51.6% | 650,000 | -26.6% | 0.37% | -51.1% |
| HSAQ | New | HEALTH SCIENCES ACQ CORP 2 | $8,800,000 | – | 800,000 | +100.0% | 0.34% | – |
| ITOS | New | ITEOS THERAPEUTICS INC | $8,635,000 | – | 350,000 | +100.0% | 0.33% | – |
| BCTG | New | BCTG ACQUISITION CORP | $8,365,000 | – | 800,000 | +100.0% | 0.32% | – |
| TARA | New | PROTARA THERAPEUTIC INC | $7,574,000 | – | 450,000 | +100.0% | 0.29% | – |
| RACA | New | THERAPEUTICS ACQUISITION COR | $7,190,000 | – | 500,000 | +100.0% | 0.28% | – |
| MORF | New | MORPHIC HLDG INC | $6,835,000 | – | 250,000 | +100.0% | 0.26% | – |
| TCDA | Sell | TRICIDA INC | $6,595,000 | -72.5% | 727,975 | -16.5% | 0.25% | -72.2% |
| ALLK | Sell | ALLAKOS INC | $6,109,000 | -57.0% | 75,000 | -62.0% | 0.24% | -56.6% |
| GTH | GENETRON HLDGS LTDads | $5,970,000 | -1.1% | 500,000 | 0.0% | 0.23% | 0.0% | |
| AVEO | Sell | AVEO PHARMACEUTICALS INC | $5,940,000 | -14.6% | 1,000,000 | -25.9% | 0.23% | -14.0% |
| FSDC | New | FS DEV CORP | $5,599,000 | – | 500,000 | +100.0% | 0.22% | – |
| SRNE | New | SORRENTO THERAPEUTICS INCcall | $5,575,000 | – | 500,000 | +100.0% | 0.21% | – |
| MRUS | Sell | MERUS N V | $5,151,000 | -46.6% | 429,284 | -28.5% | 0.20% | -46.2% |
| FIXX | Sell | HOMOLOGY MEDICINES INC | $5,039,000 | -39.7% | 470,897 | -14.4% | 0.19% | -39.2% |
| AUTL | Sell | AUTOLUS THERAPEUTICS PLCspon ads | $4,914,000 | -36.1% | 422,167 | -12.0% | 0.19% | -35.7% |
| KZR | Sell | KEZAR LIFE SCIENCES INC | $4,510,000 | -33.0% | 931,800 | -28.3% | 0.17% | -32.7% |
| BCEL | Sell | ATRECA INC | $4,100,000 | -40.0% | 293,500 | -8.7% | 0.16% | -39.5% |
| VSPRU | New | VESPER HEALTHCARE ACQSTN CORunit 99/99/9999 | $4,104,000 | – | 400,000 | +100.0% | 0.16% | – |
| KDMN | Sell | KADMON HOLDINGS INC | $3,920,000 | -57.5% | 1,000,000 | -44.4% | 0.15% | -57.1% |
| EIGR | Sell | EIGER BIOPHARMACEUTICALS INC | $3,659,000 | -45.6% | 449,510 | -35.8% | 0.14% | -44.9% |
| AVRO | Sell | AVROBIO INC | $3,177,000 | -42.7% | 244,032 | -23.2% | 0.12% | -42.2% |
| GOSS | Sell | GOSSAMER BIO INC | $3,082,000 | -32.1% | 248,382 | -28.9% | 0.12% | -31.2% |
| PANAU | New | PANACEA ACQUISITION CORPunit 99/99/9999 | $3,000,000 | – | 250,000 | +100.0% | 0.12% | – |
| CRDF | New | CARDIFF ONCOLOGY INC | $2,483,000 | – | 175,000 | +100.0% | 0.10% | – |
| ARNA | Sell | ARENA PHARMACEUTICALS INC | $2,244,000 | -52.5% | 30,000 | -60.0% | 0.09% | -52.2% |
| DTIL | PRECISION BIOSCIENCES INC | $2,135,000 | -26.0% | 346,524 | 0.0% | 0.08% | -25.5% | |
| AMRN | Sell | AMARIN CORP PLCspons adr new | $1,263,000 | -69.6% | 300,000 | -50.0% | 0.05% | -69.0% |
| ORTX | ORCHARD THERAPEUTICS PLCads | $1,055,000 | -31.5% | 256,649 | 0.0% | 0.04% | -30.5% | |
| NKTR | Sell | NEKTAR THERAPEUTICS | $830,000 | -71.3% | 50,000 | -60.0% | 0.03% | -70.9% |
| NERV | Sell | MINERVA NEUROSCIENCES INC | $759,000 | -59.0% | 238,817 | -53.4% | 0.03% | -59.2% |
| FATE | Sell | FATE THERAPEUTICS INC | $600,000 | -65.0% | 15,000 | -70.0% | 0.02% | -64.6% |
| OTLKW | OUTLOOK THERAPEUTICS INC*w exp 02/18/202 | $54,000 | -53.8% | 416,666 | 0.0% | 0.00% | -50.0% | |
| XFOR | Exit | X4 PHARMACEUTICALS INC -CW24 | $0 | – | -328,980 | -100.0% | -0.07% | – |
| ARYBU | Exit | ARYA SCIENCES ACQUISITION COunit 06/09/2027 | $0 | – | -400,000 | -100.0% | -0.18% | – |
| BNR | Exit | BURNING ROCK BIOTECH LTDsponsored ads | $0 | – | -250,000 | -100.0% | -0.26% | – |
| NXTC | Exit | NEXTCURE INC | $0 | – | -693,971 | -100.0% | -0.57% | – |
| STSA | Exit | SATSUMA PHARMACEUTICALS INC | $0 | – | -798,905 | -100.0% | -0.88% | – |
| PRNB | Exit | PRINCIPIA BIOPHARMA INC | $0 | – | -1,590,493 | -100.0% | -3.63% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-11-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| QUOTIENT LTD | 30 | Q3 2021 | 4.3% |
| ASCENDIS PHARMA A/S | 30 | Q4 2022 | 4.8% |
| MINERVA NEUROSCIENCES INC | 29 | Q3 2021 | 4.4% |
| ACCELERON PHARMA INC | 28 | Q2 2021 | 3.4% |
| OMEROS CORP | 27 | Q3 2021 | 6.5% |
| MIRATI THERAPEUTICS INC | 25 | Q4 2022 | 7.6% |
| BLUEPRINT MEDICINES CORP | 25 | Q3 2021 | 3.6% |
| APELLIS PHARMACEUTICALS INC | 24 | Q3 2023 | 8.6% |
| NEUROCRINE BIOSCIENCES INC | 24 | Q1 2020 | 4.6% |
| ROCKET PHARMACEUTICALS, INC | 23 | Q3 2023 | 2.4% |
View Cormorant Asset Management, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Ambrx Biopharma Inc. | March 13, 2023 | 42,771,365 | - |
| Altimmune, Inc. | February 14, 2023 | 2,600,000 | - |
| Arcellx, Inc. | February 14, 2023 | 2,075,000 | - |
| BioAtla, Inc. | February 14, 2023 | 2,499,250 | - |
| Eledon Pharmaceuticals, Inc. | February 14, 2023 | 1,391,663 | - |
| GreenLight Biosciences Holdings, PBC | February 14, 2023 | 4,751,020 | - |
| Prometheus Biosciences, Inc. | February 14, 2023 | 700,000 | - |
| Tango Therapeutics, Inc. | February 14, 2023 | 1,000,000 | - |
| VectivBio Holding AG | February 14, 2023 | 1,515,087 | - |
| Viridian Therapeutics, Inc.\DE | February 14, 2023 | 1,100,000 | - |
View Cormorant Asset Management, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-04-22 |
| SC 13G/A | 2024-04-15 |
| 4 | 2024-04-03 |
| SC 13G | 2024-03-21 |
| 4 | 2024-03-18 |
| SC 13G/A | 2024-03-18 |
| 4 | 2024-03-11 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View Cormorant Asset Management, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.